A citation-based method for searching scientific literature


List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
83
66

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
66

Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Eugenia Fraile-Bethencourt, Beatriz Díez-Gómez, Valeria Velásquez-Zapata, Alberto Acedo, David J Sanz, Eladio A Velasco. PLoS Genet 2017
32
66


Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer.
Talia Golan, Alex Barenboim, Guy Lahat, Ido Nachmany, Yacov Goykhman, Einat Shacham-Shmueli, Naama Halpern, Eli Brazowski, Ravit Geva, Ido Wolf,[...]. Ann Surg Oncol 2020
26
33

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
756
33

Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma.
Haijie Hu, Yayun Zhu, Ning Pu, Richard A Burkhart, William Burns, Daniel Laheru, Lei Zheng, Jin He, Michael G Goggins, Jun Yu. J Am Coll Surg 2020
7
33

Clinical outcomes in pancreatic adenocarcinoma associated with BRCA-2 mutation.
Ojas Vyas, Keith Leung, Leslie Ledbetter, Kristin Kaley, Teresa Rodriguez, Marie C Garcon, Muhammad W Saif. Anticancer Drugs 2015
27
33

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
235
33

Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX.
Amikar Sehdev, Olumide Gbolahan, Brad A Hancock, Melissa Stanley, Safi Shahda, Jun Wan, Howard H Wu, Milan Radovich, Bert H O'Neil. Clin Cancer Res 2018
36
33

PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications.
Heng Zhu, Miaoyan Wei, Jin Xu, Jie Hua, Chen Liang, Qingcai Meng, Yiyin Zhang, Jiang Liu, Bo Zhang, Xianjun Yu,[...]. Mol Cancer 2020
65
33

Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.
Mišo Gostimir, Sean Bennett, Terence Moyana, Harman Sekhon, Guillaume Martel. BMC Cancer 2016
19
33

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
225
33

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.
Talia Golan, Tal Sella, Eileen M O'Reilly, Matthew H G Katz, Ron Epelbaum, David P Kelsen, Ayelet Borgida, Hannah Maynard, Hedy Kindler, Eitan Friedmen,[...]. Br J Cancer 2017
45
33

Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.
Alexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, Katja Steiger, Björn Konukiewitz, Andreas Trumpp, Roland Eils, Jens Werner, Helmut Friess, Irene Esposito,[...]. Clin Cancer Res 2018
55
33

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.
Maeve A Lowery, David P Kelsen, Zsofia K Stadler, Kenneth H Yu, Yelena Y Janjigian, Emmy Ludwig, David R D'Adamo, Erin Salo-Mullen, Mark E Robson, Peter J Allen,[...]. Oncologist 2011
165
33

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.
Max M Wattenberg, Daniella Asch, Shun Yu, Peter J O'Dwyer, Susan M Domchek, Katherine L Nathanson, Mark A Rosen, Gregory L Beatty, Evan S Siegelman, Kim A Reiss. Br J Cancer 2020
65
33

Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Margaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, Stephen W Behrman, Al B Benson, Dana B Cardin, E Gabriela Chiorean, Vincent Chung, Brian Czito, Marco Del Chiaro,[...]. J Natl Compr Canc Netw 2021
82
33

Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis.
Ernesto Barzola Navarro, Emilio Vicente López, Yolanda Quijano, Riccardo Caruso, Valentina Ferri, Hipolito Durand, Isabel Fabra Cabrera, Eduardo Diaz Reques, Benedetto Ielpo, Anastasiia Yuriyivna Glagolieva,[...]. Ann Hepatobiliary Pancreat Surg 2019
7
33


Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis.
Taiane F Rebelatto, Maicon Falavigna, Marta Pozzari, Francesca Spada, Chiara A Cella, Alice Laffi, Stefania Pellicori, Nicola Fazio. Cancer Treat Rev 2019
21
33

Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.
Michela Capello, Minhee Lee, Hong Wang, Ingrid Babel, Matthew H Katz, Jason B Fleming, Anirban Maitra, Huamin Wang, Weihua Tian, Ayumu Taguchi,[...]. J Natl Cancer Inst 2015
50
33


Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014
232
33


Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Florian Hohla, Georg Hopfinger, Franz Romeder, Gabriel Rinnerthaler, Angelika Bezan, Stefan Stättner, Cornelia Hauser-Kronberger, Hanno Ulmer, Richard Greil. Int J Oncol 2014
28
33

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
33

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.
J Iqbal, A Ragone, J Lubinski, H T Lynch, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen, S L Neuhausen,[...]. Br J Cancer 2012
157
33

Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report.
Hideki Shimmura, Hidekazu Kuramochi, Norie Jibiki, Satoshi Katagiri, Takayoshi Nishino, Tatsuo Araida. Jpn J Clin Oncol 2019
4
33

Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy.
Amir Sonnenblick, Luna Kadouri, Liat Appelbaum, Tamar Peretz, Michal Sagi, Yael Goldberg, Ayala Hubert. Cancer Biol Ther 2011
46
33

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
Qing Zhao, Asif Rashid, Yun Gong, Matthew H Katz, Jeffrey E Lee, Robert Wolf, Aparna Balachandran, Gauri R Varadhachary, Peter W Pisters, Hua Wang,[...]. Ann Diagn Pathol 2012
77
33

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
33

Hallmarks of 'BRCAness' in sporadic cancers.
Nicholas Turner, Andrew Tutt, Alan Ashworth. Nat Rev Cancer 2004
33

BRCA2 germline mutations in familial pancreatic carcinoma.
Stephan A Hahn, Bill Greenhalf, Ian Ellis, Mercedes Sina-Frey, Harald Rieder, Birgit Korte, Berthold Gerdes, Ralf Kress, Andreas Ziegler, John A Raeburn,[...]. J Natl Cancer Inst 2003
331
33

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients.
Fleur van der Sijde, Eveline E Vietsch, Dana A M Mustafa, Marc G Besselink, Bas Groot Koerkamp, Casper H J van Eijck. Cancers (Basel) 2019
14
33

GeneSplicer: a new computational method for splice site prediction.
M Pertea, X Lin, S L Salzberg. Nucleic Acids Res 2001
341
33

Hereditary ovarian cancer in Ashkenazi Jews.
Luis Robles-Díaz, Deborah J Goldfrank, Noah D Kauff, Mark Robson, Kenneth Offit. Fam Cancer 2004
23
33

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
Amanda B Spurdle, Sue Healey, Andrew Devereau, Frans B L Hogervorst, Alvaro N A Monteiro, Katherine L Nathanson, Paolo Radice, Dominique Stoppa-Lyonnet, Sean Tavtigian, Barbara Wappenschmidt,[...]. Hum Mutat 2012
197
33

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020
6
33

In silico prediction of splice-altering single nucleotide variants in the human genome.
Xueqiu Jian, Eric Boerwinkle, Xiaoming Liu. Nucleic Acids Res 2014
230
33

RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
Hui Y Xiong, Babak Alipanahi, Leo J Lee, Hannes Bretschneider, Daniele Merico, Ryan K C Yuen, Yimin Hua, Serge Gueroussov, Hamed S Najafabadi, Timothy R Hughes,[...]. Science 2015
579
33

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.
Sharon E Plon, Diana M Eccles, Douglas Easton, William D Foulkes, Maurizio Genuardi, Marc S Greenblatt, Frans B L Hogervorst, Nicoline Hoogerbrugge, Amanda B Spurdle, Sean V Tavtigian. Hum Mutat 2008
576
33

Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
Min-Kyung So, Tae-Dong Jeong, Woosung Lim, Byung-In Moon, Nam Sun Paik, Seung Cheol Kim, Jungwon Huh. Breast Cancer 2019
19
33

Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes.
Kian Huat Lim, Luciana Ferraris, Madeleine E Filloux, Benjamin J Raphael, William G Fairbrother. Proc Natl Acad Sci U S A 2011
173
33

usDSM: a novel method for deleterious synonymous mutation prediction using undersampling scheme.
Xi Tang, Tao Zhang, Na Cheng, Huadong Wang, Chun-Hou Zheng, Junfeng Xia, Tiejun Zhang. Brief Bioinform 2021
2
50

Understanding of BRCA VUS genetic results by breast cancer specialists.
B K Eccles, E Copson, T Maishman, J E Abraham, D M Eccles. BMC Cancer 2015
63
33

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
33

Improved splice site detection in Genie.
M G Reese, F H Eeckman, D Kulp, D Haussler. J Comput Biol 1997
33

Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants.
Pascaline Gaildrat, Audrey Killian, Alexandra Martins, Isabelle Tournier, Thierry Frébourg, Mario Tosi. Methods Mol Biol 2010
90
33

BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Ang Li, Rong Xie, Qihuan Zhi, Yixiao Deng, Yangming Wu, Weiwei Li, Lu Yang, Zinan Jiao, Jiaqi Luo, Yi Zi,[...]. Gynecol Oncol 2018
21
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.